ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
SPDR S&P Telecom ETF

SPDR S&P Telecom ETF (XTL)

109.6408
1.94
(1.80%)
終了 11月25日 6:00AM
109.4935
-0.1473
(-0.13%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
109.6408
買値
-
売値
-
出来高
9,666
108.41 日の範囲 109.8762
67.08 52 週間の範囲 110.38
時価総額
前日終値
107.70
始値
108.41
最終取引時間
財務取引量
US$ 1,056,610
VWAP
109.312
平均取引量 (3 か月)
12,917
発行済株式数
775,000
配当利回り
-
PER
-2,494.08
1 株当たり利益 (EPS)
-0.04
歳入
671k
純利益
-34k

SPDR S&P Telecom ETF について

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the telecommunications segment of a U. In seeking to track the performance of the S&P Telecom Select Industry Index (the index), the fund e... The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the telecommunications segment of a U. In seeking to track the performance of the S&P Telecom Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the telecommunications segment of the S&P Total Market Index (S&P TMI). 詳細を表示

セクター
Mgmt Invt Offices, Open-end
業界
Mgmt Invt Offices, Open-end
ウェブサイト
本社
Boston, Massachusetts, USA
設立
-
SPDR S&P Telecom ETF is listed in the Mgmt Invt Offices, Open-end sector of the アメリカ証券取引所 with ticker XTL. The last closing price for SPDR S&P Telecom ETF was US$107.70. Over the last year, SPDR S&P Telecom ETF shares have traded in a share price range of US$ 67.08 to US$ 110.38.

SPDR S&P Telecom ETF currently has 775,000 shares in issue. The market capitalisation of SPDR S&P Telecom ETF is US$83.47 million. SPDR S&P Telecom ETF has a price to earnings ratio (PE ratio) of -2494.08.

XTL 最新ニュース

XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives

VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLBNASDAQ:TASE:NASDAQ:XTL) today announced an update to its December 8, 2008 press release regarding...

XTLbio Announces Grant of hMAb Patent

XTLbio Announces Grant of Human Monoclonal Antibody Patent Patent Covers Antibodies Directed Against Hepatitis B Virus Surface Antigen Rehovot, Israel 26 January 2004 - XTL Biopharmaceuticals...

XTLbio appoints Stockbroker and Financial Adviser

XTLbio appoints Stockbroker and Financial Adviser Rehovot, 20 January 2004 - The Board of XTL Biopharmaceuticals Ltd ("XTLbio" or the "Company") is pleased to announce the appointment of Code...

XTLbio announces appointment of Non-Executive Director

XTLbio announces appointment of Non-Executive Director Rehovot, 12 January 2004 - XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Peter Stalker, III, as a...

Business Update

RNS Number:2908T XTL Biopharmaceuticals Limited 16 December 2003 XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today...

XTLbio R&D and Business Development Update

XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today announces an update on recent clinical progress and corporate developments...

XTLbio Highlights Presence at The Liver Meeting

XTLbio Highlights Presence at The Liver Meeting HepeX Programs at 54th Annual AASLD include Poster Presentations, Oral Presentation and Exhibitors Booth Rehovot, Israel, 28 October 2003: XTL...

Directorate Change

XTLbio announces appointment of Non-Executive Director Rehovot, Israel, 20 October 2003: XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the appointment of Dr. Hadar Ron as a...

Holding(s) in Company

NOTIFICATION OF MAJOR INTERESTS IN SHARES 1) Name of company XTL Biopharmaceuticals Limited 2) Name of shareholder having a major interest Perpetual Income & Growth Investment Trust plc 3) Please...

XTLbio ACQUIRES RIGHTS FROM STANFORD UNIVERSITY

XTLbio ACQUIRES BROAD RIGHTS FROM STANFORD UNIVERSITY TO ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS (HCV) Exclusive license enhances XTLbio's HepeX-C program in clinical development Rehovot...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
13.31083.11370262391106.33109.4935103.0313447105.05440313SP
47.40087.2386541471102.24110.38100.8715917105.84941372SP
1216.120817.237810094193.52110.3891.3812917101.90547127SP
2635.480847.843581445574.16110.3872.41531055294.04617864SP
5239.650856.652093156269.99110.3867.08746788.80078445SP
1569.31089.28017542111100.33110.3864.09707484.20002839SP
26041.240860.293567251568.4110.3848.47923985.62286132SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.41M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.36M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
95.06M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
103.6M

最近閲覧した銘柄

Delayed Upgrade Clock